CLINICAL_TRIALS
trial_result
· 2015-09-09
Clinical Trial Update: Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma [Phase 2]
Summary
A Phase 2 imaging trial of the radiopharmaceutical I-124-CLR1404 for glioblastoma was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cellectar Biosciences, Inc. | Conditions: Glioblastoma | Phase 2 | Status: TERMINATED